Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Vascular Grafts Devices include Aortic Vascular Grafts and Peripheral Vascular Grafts. Vascular Grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular grafts devices market, including market shares of different players within Taiwan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the vascular grafts market in Taiwan was W. L. Gore & Associates followed by Getinge, Terumo, CR Bard, LeMaitre Vascular and B. Braun Melsungen.
Vascular Grafts are implants used to repair, bypass or replace sections of blood vessels during surgical interventions. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. Vascular Grafts are classified into autografts, allografts and synthetic vascular grafts on the basis of the materials. Autograft Vascular Grafts are vascular grafts taken from the individual and used in the same individual. These grafts are not tracked. Allograft Vascular Grafts are vascular grafts taken from another individual and used in the treated patient. Synthetic Vascular Grafts are the grafts which are manufactured using polymers. Polyester and Polytetrafluoroethylene (PTFE) are the two synthetic materials used to construct synthetic vascular grafts. Synthetic (polyethyleneterepthalate) Vascular Grafts are made from polymer yarn woven tubes whereas Synthetic PTFE Vascular Grafts are made by mechanically stretching sheets of polytetrafluoroethylene. Aortic Vascular Grafts are grafts that are used to replace and repair damaged portions of the aorta. Peripheral Vascular Grafts are grafts that are used to replace and repair damaged blood vessels outside of the aorta.
The value of the vascular grafts devices market within Taiwan was expected to be over $2m in 2023.
For the latest complete market share analysis of vascular grafts device market in Taiwan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
